Salbutamol (Albuterol) and Clenbuterol belong to the same medicine class called Beta-2 Andrenergic Receptor Agonist/Antagonist. Both medicines share the same properties and both have been used for same conditions in many medical trials. Typically used to treat Asthma, it stimulates beta-2 receptors, which medical studies have shown to extremely beneficial for Asthma as well as fat loss and strength gain. Salbutamol is thermogenic, it will increase metabolism. Some studies may suggest Salbutamol may be more effective in humans than Clenbuterol which has been studied mostly in animals. Please note that the inhaler version of the medicine is potent for asthma only, since it's dose is too small and is rapidly absorbed.
Extracts from the Medical
"Salbutamol has been proven just as efficient as clenbutrol and in
fact has been proven anabolic even in humans, while clenbuterol has been proven
anabolic in animals only. "
Journal of Sport Medicine 1997 Dec
Department of Exercise Science, School of Public Health and
Health Sciences, University of Massachusetts, Amherst,
ppm) fed to pigs between weaning and slaughter increased ADG (5%), dressing
percentage (2%) and cross-sectional area of the longissimus (LD) muscle (14%).
In fatter, White-line-sired pigs, but not in leaner, Meat-line-sired animals, it
reduced backfat thickness (25%)." (This
means increased muscle mass by 14% and fat decrease by
Journal Animal Science 1990
Warriss PD, Brown SN, Rolph TP, Kestin SC.
Institute of Food Research, Bristol Laboratory, Langford,
"The data demonstrate that
the chronic administration of therapeutic levels of salbutamol increases maximal
anaerobic power in man, irrespective of the subjects' training status"
International Sports Medicine 2005
Le Panse B, Collomp K, Portier H, Lecoq AM, Jaffre C,
Beaupied H, Richard O, Benhamou L, De Ceaurriz J, Courteix D.
Faculte des Sports, Orleans, France.
"..in response to salbutamol
administration (DeltaAIx-Salb) were determined before and after weight
reduction. After a 12-week weight reduction program, the average weight loss was
7.96 +/- 3.47 kg, with losses of 21.88 +/- 20.39 cm2 in visceral fat
Yonsei Med J. 2005
Park SH, Shim KW.
Cardiology and Ewha Medical Research
beta-adrenergic system is involved in the control of energy metabolism and
expenditure...The beta2-AR was stimulated with two doses of salbutamol...the
findings support a role for this polymorphism in the development and maintenance
of overweight and obesity"
Clinical Endocrinology Metabolism 2005
Park SH, Shim KW.
Department of Cardiology
and Ewha Medical Research Institute
"Isoproterenol and salbutamol elicited
strong lipolytic responses in adipocytes isolated from horse and pony
subcutaneous adipose tissue..."
Carrington EF, Desautels M, Naylor JM.
University of Saskatchewan, Western
College of Veterinary Medicine
"A 65-year-old Kenyan Asian developed
rapidly progressive multiple symmetrical lipomatosis over 8 years.... A clinical
trial of oral salbutamol, a beta 2-agonist, was performed with significant
therapeutic effect. The body fat mass showed a reversal of the rapid progression
while on the treatment, associated with an increase in the resting metabolic
Clinical Endocrinology 1987 Nov
Gaer J, Beggs D, Kark AE, Holloway B, Peters TJ.
Division of Clinical
Cell Biology, MRC Clinical Research Centre, Harrow, Middlesex,
"...Furthermore, continuous infusion of
salbutamol (1.15 mg.kg body wt-1.day-1) via miniosmotic pumps did cause
significant increases in muscle mass, protein..."
American Journal of
JJ, Horan MA, Little RA, Rothwell NJ.
Department of Physiological Sciences,
University of Manchester Medical School, United Kingdom
"Eight normal male subjects received single oral
doses of BRL 35135 (8 mg) or the selective beta 2-adrenoceptor agonist
salbutamol (8 mg)... BRL 35135 and
salbutamol produced a significant fall in serum potassium concentration compared
with placebo, in keeping with beta 2-adrenoceptor stimulation...A significant increase in basal metabolic rate
occurred with both BRL 35135 and salbutamol. In the case of salbutamol, this
effect appeared to be mediated solely by beta 2-adrenoceptors."
Clinical Science (London)
NM, McDevitt DG, McFarlane LC, Lipworth BJ.
Department of Clinical
Pharmacology, Ninewells Hospital and Medical School, Dundee, Scotland,
"One group of animals (T-I) was fed salbutamol
at a dose of 2 mg x kg-1 diet x day-1 for 38 days, while in another group (T-II)
the beta-adrenergic agonist was discontinued in the diet 5 days before slaughter
on the 43rd day. The semitendinosus muscle protein content increased (p <
0.05), while fat and collagen content decreased (p < 0.05) in the T-I group.
These differences were not apparent in the group from which salbutamol was
withdrawn. The data show that
salbutamol is able to increase muscle content at the expense of fat stores in
An. Nutrition &
Barrio AS, Garcia-Calonge MA, Fernandez-Quintela A, Simon E, Portillo MP,
Astiasaran I, Martinez JA.
Department of Nutrition and Food Science,
University of Pais Vasco, Vitoria, Spain.
We do not
encourage of the use of Salbutamol for any other uses than strict therapeutical
under a licensed physician care. Salbutamol is a potent medicine, use with care.
Information presented is not medically approved, may be inaccurate and is unreliable. It can not and must not serve as any basis of decision making regarding any health concern or issue.
We sell the original Ventolin (Salbutamol) tablets.
Tablets and infusion are the only valid methods used in the above medical studies. The inhaler version of Salbutamol will NOT produce the same results as described in the medical studies above, the inhaler is only good for selected asthma conditions.
| || |